Table of Contents
Point of Care (POC) Cholesterol Testing Market analyzes the market for cholesterol testing performed at or near the site where the patient is located. The report examines the following components of the POC cholesterol market:
Global POC Cholesterol Testing Market Analysis, 2012-2020
POC Cholesterol Self-Testing Market Analysis, 2015 and 2020
POC Cholesterol Professional Testing Market Analysis, 2015 and 2020
Global POC Cholesterol Testing Market Revenues and Market Share of Leading Suppliers, 2014
Global POC Cholesterol Testing Manufacturers by Percent, 2014
One of the key benefits and market drivers for the point of care (POC) testing market is the ability to have rapid results that can be used immediately for patient treatment decisions. Professional sector testing comprises tests used in hospitals, physician offices and clinics. In the core lab, cholesterol testing has gained importance, driven by growing awareness about the risks of heart attack and increasing realization among individuals to control their cholesterol levels. Patient self-testing comprises a smaller segment of the market, as this has not caught the imagination of consumers, one of the major issues being that of test interpretation, not so much of the actual result but what the result implies.
Overall growth in testing volume is driven by factors such as aging population and growing number of people at risk of cardiovascular disease including those with hypertension, diabetes mellitus, and abdominal obesity.
The top and/or innovative companies in the market are discussed within Corporate Profiles, including Alere and Roche.
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
This 1,007-page report provides a comprehensive analysis of the emerging POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, ...
With 14.5% CAGR, point of care testing segment is the largest segment among the global microfluidics market application segments By the end of 2026, the point of care testing segment is projected to reach ...
IVD Market expected to increase to $76 billion by 2023, increasing its influence over healthcare spending globally Description In-Vitro diagnostics (IVD) is a broad term which refers to the use of medical ...